GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
11.4578 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
11.4578 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, EPHX2, F10, F3, FABP3, FABP4, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
11.4578 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, EPHX2, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, PRKCA, SMAD3, SRC, TEK, TOP1, TYR |
9.01375 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.83668 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.75899 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, F3, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
8.75899 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.75899 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, AURKB, AXL, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, EPHX2, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPRS, SRC, TEK, TNKS, TOP1, XDH |
8.15394 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, PRKCA, SMAD3, SRC, TEK, TYR |
8.00555 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, EPHX2, FABP3, FABP4, FDPS, HSD17B1, HSD17B2, MET, PPARA |
7.96575 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.84121 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, AURKB, AXL, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, EPHX2, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPRS, SRC, TEK, TNKS, TOP1, XDH |
7.84121 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
7.78424 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.62933 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP2, MMP9, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.33705 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PRKCA, SRC, TEK, XDH |
7.33425 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.30744 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AXL, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PRKCA, SRC, TEK, XDH |
6.90631 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.73807 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, CSNK2A1, CYP1B1, DRD2, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCA, SMAD3, SRC, TEK, XDH |
6.62439 |
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
6.62371 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX15, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, F3, FABP4, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TNKS2, TOP1, TYR |
6.62294 |
[BP] GO:0030334 |
regulation of cell migration
|
CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
6.60682 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
6.51487 |
[BP] GO:2000147 |
positive regulation of cell motility
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
6.5062 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PRKCA, SMAD3, SRC, TEK |
6.4979 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
6.4979 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.44098 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
6.42777 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TNKS, TOP1 |
6.42777 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX2, FABP3, FDPS, HSPA1A, PIM1, PPARA, TYR, XDH |
6.39523 |
[BP] GO:2000145 |
regulation of cell motility
|
CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
6.33433 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, F3, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
6.33433 |
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
6.28576 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, EPHX2, FABP3, FABP4, FDPS, MET, PPARA |
6.28557 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
6.16578 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, SRC, TEK, TYR |
6.15147 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, CYP19A1, DRD2, DUSP3, EGFR, F3, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, XDH |
6.04158 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, PRKCA, SRC, TEK, TNKS, TOP1 |
5.98962 |
[BP] GO:0040012 |
regulation of locomotion
|
CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
5.91601 |
[BP] GO:0051270 |
regulation of cellular component movement
|
CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
5.90374 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.89977 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD17B2, INSR, KDR, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
5.87409 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.85511 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, F3, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
5.57911 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK |
5.5787 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
5.42798 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, EPHX2, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PPARA, PRKCA, SMAD3, SRC, TEK, TOP1, TYR |
5.38446 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
5.37956 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
5.37436 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK, XDH |
5.34611 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TNKS, TOP1 |
5.31344 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, SRC, TEK |
5.31344 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK |
5.2891 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
5.21903 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, DRD2, EGFR, F3, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, TEK |
5.20213 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK, XDH |
5.13709 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
5.1225 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, EPHX2, HSPA1A |
5.08479 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD1, DRD2, EGFR, F3, FABP4, KDR, MET, MMP12, PPARA, PRKCA, PTPRS, SMAD3, TEK |
5.00426 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS, HSD17B1, HSD17B2 |
5.00426 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, SMAD3, SRC, TEK |
4.87065 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS2, TYR |
4.80972 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.80972 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.80258 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, CA2, CSNK2A1, CYP1A2, DRD1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
4.65754 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC |
4.57483 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK |
4.57483 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK, XDH |
4.50513 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, DRD2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.49969 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.43386 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PPARA |
4.40487 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA2, CA4, CA7 |
4.40381 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, AXL, CA12, CA2, CA7, DRD1, DRD2, EGFR, EPHX2, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
4.40381 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, HSD17B1, HSD17B2, PRKCA |
4.35495 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
4.35112 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSD17B2, INSR, KDR, MMP9, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
4.35112 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PRKCA, SMAD3, SRC, TEK, XDH |
4.34376 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PRKCA, SMAD3, SRC, TEK, XDH |
4.29368 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.28886 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, FDPS, TYR |
4.24055 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, EGFR, TNKS, TNKS2 |
4.24055 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
4.18503 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
4.14036 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, DRD1, DRD2, EGFR, EPHX2, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
4.14036 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, TYR |
4.13671 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, EPHX2 |
4.13663 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
4.07203 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
4.03685 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, AURKB, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, XDH |
4.03685 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, EGFR, GPR35, HSPA1A, INSR, MMP12, MMP9, PPARA, PRKCA, SMAD3, SRC |
3.97024 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, CYP19A1, DRD1, DRD2, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
3.9613 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.93189 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FDPS |
3.93163 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.91135 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, EGFR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TYR |
3.88852 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CSNK2A1, CYP1B1, DRD2, DUSP3, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, SRC, TNKS |
3.87447 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, AURKB, AXL, CSNK2A1, DRD1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
3.86908 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, DRD2, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PRKCA, SRC, TEK, XDH |
3.86595 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
3.86272 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
3.83189 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FLT3, SRC, TEK, TYR |
3.83189 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, EGFR, KDR, SRC, TNKS, TNKS2 |
3.81105 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, AKR1B1, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, F3, FABP3, FABP4, FDPS, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
3.77922 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, KDR, SRC, TOP1 |
3.77922 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, DUSP3, EGFR, KDR, PRKCA, SRC, TEK |
3.73198 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
3.69496 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, AXL, CYP1A1, CYP1B1, DRD1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, SMAD3, SRC |
3.69426 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.69426 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, AURKB, CSNK2A1, DRD1, DRD2, EGFR, EPHX2, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.68626 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, AURKB, CSNK2A1, DRD1, DRD2, EGFR, EPHX2, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.66822 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.66662 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.62817 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, EGFR, KDR, PRKCA, SRC, TEK |
3.62817 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FDPS |
3.61932 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, SRC, TEK |
3.61932 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, FDPS, HSD17B1, HSD17B2 |
3.60204 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, DRD2, EGFR, FLT3, INSR, KDR, PRKCA, SRC, TEK, XDH |
3.57128 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, DRD2, EGFR, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTPRS, SMAD3, SRC, TEK |
3.52409 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, EPHX2, KDR, SRC |
3.52261 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, DRD1, DRD2, EGFR, FABP3, FLT3, INSR, KDR, MMP9, PRKCA, SMAD3, SRC, TEK, XDH |
3.50772 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, DRD1, DRD2, EGFR, FABP3, FLT3, INSR, KDR, MMP9, PRKCA, SMAD3, SRC, TEK, XDH |
3.50772 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA1, CA12, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, F3, FABP3, FABP4, FDPS, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, XDH |
3.49953 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX2, FABP3, FABP4, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.49953 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CYP1A1, EGFR, FLT3, MET, PIM1, SRC, TEK, TYR |
3.49953 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, PPARA, SRC, TEK |
3.47164 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, DRD1, DRD2, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPRS, SMAD3, SRC, XDH |
3.47164 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, DRD1, DRD2, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPRS, SMAD3, SRC, XDH |
3.45983 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
3.45983 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, AURKB, CSNK2A1, DRD1, DRD2, EGFR, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.45983 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.45375 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.45375 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA2, CA4, CA7, DRD2, FABP3, PPARA |
3.42781 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.41092 |
[BP] GO:0050790 |
regulation of catalytic activity
|
AURKB, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PRKCA, SMAD3, SRC, TEK, TNKS, XDH |
3.37635 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 |
3.34953 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PRKCA, SRC, TEK, XDH |
3.34817 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, FDPS, HSD17B1, HSD17B2 |
3.34266 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.2998 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.28343 |
[BP] GO:0050678 |
None
|
EGFR, F3, KDR, MMP12, PRKCA, SMAD3, TEK, XDH |
3.25564 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, CA2, CYP1B1, DRD2, EGFR, F3, HSPA1A, KDR, MET, MMP12, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK |
3.25454 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, AURKB, DRD1, DRD2, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.22386 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, SRC, TYR |
3.16445 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PRKCA, SRC, TEK, XDH |
3.15241 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.13011 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PRKCA, SRC, TEK, XDH |
3.12493 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, SMAD3, SRC |
3.1045 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
3.09105 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, CYP3A4, FDPS, TYR |
3.08764 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, DRD1, PRKCA, SRC, TNKS, TOP1 |
3.0442 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, EGFR, INSR, SMAD3 |
3.0199 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PPARA |
3.00949 |
[BP] GO:0044419 |
interspecies interaction between organisms
|
AXL, EGFR, FDPS, HSPA1A, INSR, KDR, MET, MMP1, SMAD3, SRC, TOP1 |
3.00877 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, EPHX2, FABP3, FDPS, FLT3, PPARA, SRC, TEK |
2.99176 |
[BP] GO:0001666 |
response to hypoxia
|
CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
2.98466 |
[BP] GO:0031348 |
negative regulation of defense response
|
CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
2.96993 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, HSPA1A, KDR, MET, MMP1, PRKCA, SMAD3, SRC, TEK |
2.96993 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.95851 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
AURKB, CYP1A1, DRD2, DUSP3, EGFR, INSR, PRKCA, SRC |
2.94459 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.94459 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.94459 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.94459 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.94459 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.94459 |
[BP] GO:0050679 |
None
|
EGFR, F3, KDR, MMP12, PRKCA, TEK |
2.93246 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2 |
2.92864 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
2.9262 |
[BP] GO:0044267 |
cellular protein metabolic process
|
AURKB, AXL, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.92356 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, DRD1, PRKCA, SRC, TNKS, TOP1 |
2.81878 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.81525 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
CYP19A1, DRD1, DRD2, PPARA, PTPRS, SMAD3, TEK |
2.81473 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, KDR, MET, PRKCA, SMAD3 |
2.81473 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
2.78812 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, AURKB, AXL, CSNK2A1, DRD2, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.78812 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, AXL, CA2, CYP19A1, DRD1, DRD2, EGFR, INSR, MMP12, SMAD3, SRC |
2.78812 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.78789 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, EGFR, PPARA, SRC, TOP1 |
2.77672 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
AURKB, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3, TNKS |
2.77478 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.76503 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.76503 |
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.72999 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX2 |
2.72999 |
[BP] GO:0050801 |
ion homeostasis
|
CA12, CA2, CA7, DRD1, DRD2, EGFR, EPHX2, FABP3, GPR35, SMAD3 |
2.72999 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PPARA, PRKCA, SMAD3, SRC, TEK |
2.72999 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET |
2.72572 |
[BP] GO:0070482 |
response to oxygen levels
|
CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
2.72572 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.68439 |
[BP] GO:0051726 |
regulation of cell cycle
|
AURKB, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3, SRC, TNKS |
2.68098 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.6656 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA2, CA4, CA7, DRD2, FABP3, PPARA |
2.65281 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.65281 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.65281 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
AXL, CA2, CYP1B1, DRD2, EGFR, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIM1, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
2.63983 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
CA2, CA7, DRD1, DRD2, EGFR |
2.63181 |
[BP] GO:0006464 |
cellular protein modification process
|
AURKB, AXL, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.6295 |
[BP] GO:0036211 |
protein modification process
|
AURKB, AXL, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.6295 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.61909 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.60533 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.60533 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
CA2, CA7, DRD1, DRD2, KDR, SRC |
2.5835 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, KDR, MET, MMP1, MMP12, MMP9, SRC, TEK |
2.57994 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PIM1, PPARA, TYR |
2.57915 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ALOX15, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, EPHX2, F3, FABP3, FABP4, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, XDH |
2.57658 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.52337 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PRKCA, SMAD3, SRC, TEK, XDH |
2.51659 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, SRC, TEK |
2.51659 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.50343 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.494 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.4884 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, CSNK2A1, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, KDR, MMP9, PRKCA, SMAD3, SRC, TEK, XDH |
2.47069 |
[BP] GO:0001936 |
None
|
F3, KDR, PRKCA, TEK, XDH |
2.4687 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.43785 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43785 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.40493 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.40493 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.40493 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.39447 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, IGF1R, INSR, MMP2, MMP9, SRC |
2.36493 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.35705 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.35705 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.35705 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.35705 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.35705 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.35705 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.35705 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, MET, MMP9, PPARA, SMAD3, SRC, TNKS |
2.35705 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.34444 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.33584 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
2.315 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.315 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.28483 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.28483 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.28449 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, DRD1, PRKCA |
2.2756 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.26851 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, DRD2, EGFR, FLT3, INSR, KDR, MMP9, PRKCA, SRC, TEK, XDH |
2.26529 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PIM1, PPARA, TYR |
2.25855 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.25241 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, TYR |
2.25241 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.23769 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.23769 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.23769 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.23769 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.23769 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, PRKCA, TEK |
2.23395 |
[BP] GO:0003018 |
None
|
DRD1, EGFR, EPHX2, SRC, TEK |
2.22206 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PIM1, PPARA, TYR |
2.21355 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, CYP1B1, DRD1, DRD2, EGFR, IGF1R, INSR, KDR, MET, NUAK1, PRKCA, SRC, TEK |
2.21355 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.21355 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.21355 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
CA12, CA2, CA7, DRD1, DRD2, EGFR, EPHX2, GPR35, SMAD3 |
2.21355 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.21231 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, KDR, MMP9, PRKCA, SMAD3, SRC, TEK, XDH |
2.20608 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.19697 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, AURKB, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, MET, MMP9, SMAD3, SRC, TEK, TNKS, XDH |
2.18721 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.18162 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.18162 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA1, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, F3, FABP3, FABP4, FDPS, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, XDH |
2.17392 |
[BP] GO:0040008 |
regulation of growth
|
CSNK2A1, DRD2, EGFR, HSPA1A, INSR, PIM1, PTPRS, SMAD3, TNKS2 |
2.17099 |
[BP] GO:0010595 |
positive regulation of endothelial cell migration
|
KDR, MET, PRKCA, TEK |
2.14641 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR |
2.14641 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.14641 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, DRD2, EGFR, FLT3, INSR, KDR, MMP9, PRKCA, SRC, TEK, XDH |
2.13936 |
[BP] GO:0001938 |
None
|
F3, KDR, PRKCA, TEK |
2.13238 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13238 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DUSP3, HSPA1A, IGF1R, MET, MMP9, SRC, XDH |
2.12686 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALOX15, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PRKCA, SMAD3, SRC, TEK, XDH |
2.12131 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.11763 |
[BP] GO:0006775 |
fat-soluble vitamin metabolic process
|
CBR1, CYP1A1, CYP3A4 |
2.11763 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.11763 |
[BP] GO:0050793 |
regulation of developmental process
|
AXL, CA2, CYP1B1, DRD2, EGFR, F3, INSR, KDR, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
2.11709 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.11278 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.11278 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.11278 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.11278 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.11278 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.11278 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
DRD2, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPRS, SMAD3, SRC, XDH |
2.11082 |
[BP] GO:0051052 |
regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.11082 |
[BP] GO:0043412 |
macromolecule modification
|
AURKB, AXL, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.11082 |
[BP] GO:0016042 |
lipid catabolic process
|
CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.1018 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, SMAD3, XDH |
2.09906 |
[BP] GO:0032212 |
positive regulation of telomere maintenance via telomerase
|
AURKB, TNKS, TNKS2 |
2.09849 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
AXL, CYP1B1, DRD1, DRD2, EGFR, KDR, MMP1, MMP12, MMP9, PRKCA, SRC, TEK, TUBB3 |
2.09552 |
[BP] GO:0051704 |
multi-organism process
|
AXL, CYP1A1, EGFR, FDPS, HSPA1A, INSR, KDR, MET, MMP1, MMP12, SMAD3, SRC, TOP1 |
2.09165 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, XDH |
2.08719 |
[BP] GO:0051338 |
regulation of transferase activity
|
AURKB, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, SRC, TEK, TNKS |
2.07661 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, EGFR, IGF1R, INSR, MMP2, SRC |
2.07633 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ALOX15, AURKB, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, EPHX2, F3, FABP3, FABP4, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.07633 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, DRD1, EGFR, FLT3, IGF1R, INSR, MMP2, SMAD3, SRC |
2.0691 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, EGFR, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.0635 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ALOX15, AURKB, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, EPHX2, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, XDH |
2.05721 |
[BP] GO:0033043 |
regulation of organelle organization
|
ALOX15, AURKB, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.05084 |
[BP] GO:0050878 |
regulation of body fluid levels
|
AKR1B1, DRD2, F10, F3, MET, PRKCA, XDH |
2.05084 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, PRKCA, TEK |
2.04743 |
[BP] GO:0032205 |
None
|
SRC, TNKS, TNKS2 |
2.04394 |
[BP] GO:1904358 |
positive regulation of telomere maintenance via telomere lengthening
|
AURKB, TNKS, TNKS2 |
2.04394 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.04394 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.02125 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ALOX15, AXL, CYP19A1, DRD2, DUSP3, MMP12, PTPRS |
2.01925 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP3A4 |
2.00308 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FDPS, MET |
2.00308 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, AKR1B1, AURKB, AXL, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F3, FABP3, FABP4, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
2.95311 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, ALOX15, ALOX5, AURKB, CA1, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F10, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MMP2, MMP9, PIM1, PRKCA, PTPRS, SMAD3, SRC, TNKS, TNKS2, TOP1, TYR, XDH |
2.68098 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.64268 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ALOX15, AXL, CA2, CA4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, SRC, TEK |
2.55585 |
[CC] GO:0044421 |
None
|
ABCB1, ACHE, AKR1B1, ALOX5, AXL, CA1, CA2, CA4, CBR1, DUSP3, EGFR, EPHX2, F3, FABP3, FABP4, HSPA1A, INSR, MMP1, MMP12, MMP2, MMP9, PRKCA, PTPRS, SRC, TUBB3, XDH |
2.38633 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
AXL, CA4, DRD1, DRD2, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, TEK |
2.35705 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, F3, FABP3, FABP4, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
2.31319 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ALOX15, AXL, CA12, CA2, CA4, CSNK2A1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, PIM1, PRKCA, PTPRS, SMAD3, SRC, TEK |
2.21034 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, CA4, EGFR, HSPA1A, PRKCA, SRC, TNKS2, TYR |
2.19848 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, AXL, CA4, EGFR, F3, MET, TEK |
2.0327 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, EPHX2, F10, F3, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
15.3324 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, EPHX2, F10, F3, FDPS, FLT3, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTPRS, SRC, TEK, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
13.8713 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCA, SMAD3, TNKS, TYR, XDH |
10.6936 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PRKCA, SRC, TEK, TOP1 |
9.16652 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.91776 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.22281 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1 |
6.61168 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA2, CA4, CA7 |
6.4979 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.97808 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1 |
5.78297 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.66862 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPRS, SRC, TEK, TOP1, TUBB3, XDH |
5.62747 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AURKB, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EPHX2, F10, FDPS, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, SMAD3, TNKS, TNKS2, TYR, XDH |
5.45405 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.42457 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1 |
5.34611 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.23806 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTPRS, SRC, TEK, TOP1 |
4.85651 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
4.51926 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1 |
4.51926 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.35918 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
4.1764 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, MMP1, MMP12, MMP2, MMP9, PPARA, PRKCA, SMAD3, TNKS |
4.08305 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1, TUBB3, XDH |
4.07203 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AURKB, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX2, F10, FDPS, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, SMAD3, TNKS, TNKS2, TYR, XDH |
4.02508 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1 |
4.00476 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA2, CA4, CA7 |
4.00476 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1 |
3.88852 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1 |
3.86595 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1, TUBB3, XDH |
3.86595 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1, TUBB3, XDH |
3.86595 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.56793 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.56334 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.56334 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1, TUBB3 |
3.56334 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA2, CA4, CA7 |
3.47164 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1, TUBB3 |
3.45505 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.43212 |
[MF] GO:0017076 |
purine nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1, TUBB3 |
3.42781 |
[MF] GO:0032553 |
ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TOP1, TUBB3 |
3.42037 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC |
3.33932 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.25454 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.17956 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPRS, SRC, TEK, TOP1, TUBB3 |
3.16475 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
2.82893 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.78466 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.65281 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.54877 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.50787 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HSD17B1, HSD17B2, XDH |
2.42727 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.40493 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.40493 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, SRC, XDH |
2.27657 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.23894 |
[MF] GO:0004252 |
None
|
F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.23894 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.23769 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.23769 |
[MF] GO:0016740 |
transferase activity
|
AURKB, AXL, CSNK2A1, EGFR, FDPS, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TNKS, TNKS2, TOP1 |
2.13444 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.11278 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.11278 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.09849 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, F10, F3, FABP3, FABP4, HSD17B1, PPARA |
2.09552 |
[MF] GO:0008236 |
None
|
F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.05084 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.00308 |